Yi Larson
CIK: 0001785987
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OLMA
Olema Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Larson Yi
Larson Yi (SEC CIK 0001785987) files insider reports with the SEC as Director of Olema Pharmaceuticals, Inc. (OLMA).
Signal8 holds 2 ownership filings by Larson Yi, all Form 4s, filed between Jun 13, 2025 and Jun 23, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Larson Yi's filings is in SAN FRANCISCO, CA.
Recent filings by Larson Yi
Other insiders filing for Olema Pharmaceuticals, Inc. (OLMA)
- O'Byrne Jason, CHIEF FINANCIAL OFFICER
- Harmon Cyrus, Director
- BVF PARTNERS L P/IL, Director
- BUTITTA CYNTHIA M, Director
- Garland J. Scott, Director
- Hrustanovic Gorjan, Director